أعرض في EDS

116P Any regression of tumor (ART) as an intermediate endpoint in patients (pts) treated with immune checkpoint inhibitors (ICI): A pan-cancer analysis

التفاصيل البيبلوغرافية
العنوان:	116P Any regression of tumor (ART) as an intermediate endpoint in patients (pts) treated with immune checkpoint inhibitors (ICI): A pan-cancer analysis
المؤلفون:	T. El Zarif, G. Pond, A. Nassar, E. Adib, D. Freeman, J. Thomas, U. Kalluri, A. Matar, E. Kelly, C. Curran, A. Kadamkulam Syriac, H. McClure, M. Davidsohn, C. Labaki, R.M. Saliby, C.S. Hobeika, P.V. Nuzzo, J.E. Berchuck, T.K. Choueiri, G.P. Sonpavde
المصدر:	Annals of Oncology. 33:S591-S592
بيانات النشر:	Elsevier BV, 2022.
سنة النشر:	2022
مصطلحات موضوعية:	Oncology, Hematology
تدمد:	0923-7534
DOI:	10.1016/j.annonc.2022.07.148
URL الوصول:	https://explore.openaire.eu/search/publication?articleId=doi_________::a8ad17bc81055d23c5d59f8181539a2a https://doi.org/10.1016/j.annonc.2022.07.148
Rights:	CLOSED
رقم الانضمام:	edsair.doi...........a8ad17bc81055d23c5d59f8181539a2a
قاعدة البيانات:	OpenAIRE

الوصف
تدمد:	09237534
DOI:	10.1016/j.annonc.2022.07.148